New Facility Enables Pharmatek to Serve Growing Highly-Potent and Cytotoxic Compound Market
Open PDF Version
SAN DIEGO, Calif. – September 17, 2008
- Pharmatek – a pharmaceutical chemistry development organization supporting the pharmaceutical industry – today announced the opening of its highly-potent and cytotoxic facility located in San Diego.
The 18,000 sq. ft. facility includes newly constructed analytical and formulation development laboratories
and cGMP manufacturing suites dedicated to the development of highly-potent and cytotoxic drug
product for early phase clinical trials.
“Highly-potent and cytotoxic compounds are among the most sensitive drugs to handle and produce.”
said Kevin Rosenthal, director of manufacturing of Pharmatek. “Our primary goal when designing the
facility was to optimize product quality while ensuring operator safety to guarantee our clients’ drug
candidates move smoothly from discovery to clinical trials.”
The facility holds a State of California Food and Drug Branch (FDB) Drug Manufacturers License and is
currently working on a number of highly-potent development projects. The FDB license authorizes
Pharmatek to manufacture and ship clinical material from its state-of-the-art highly-potent and cytotoxic
manufacturing and development site.
“The highly-potent facility is a significant addition to our service offering,” said Timothy Scott, president
of Pharmatek. “We are always looking for ways to better meet our client’s drug development outsourcing
needs, and the highly-potent and cytotoxic facility strengthens our ability to provide a broader level of
services to our clients.”
About Pharmatek Laboratories, Inc.
Pharmatek Laboratories, Inc. is a premier pharmaceutical chemistry development organization supporting the pharmaceutical and biotechnology industries. Pharmatek focuses on bringing client compounds from discovery to the clinic with services that include compound selection, analytical development, preformulation testing, formulation development, GMP manufacturing, stability storage and testing, and
cytotoxic and high-potency development.
Company Contact:
Ryan Lane, Marketing Coordinator
Pharmatek Laboratories, Inc.
(858) 805-6383
rlane@pharmatek.com
|
